ELADYNOS Trademark
Trademark Overview
On Friday, February 6, 2026, a trademark application was filed for ELADYNOS with the United States Patent and Trademark Office. The USPTO has given the ELADYNOS trademark a serial number of 99637948. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, June 3, 2026. This trademark is owned by Radius Health, Inc.. The ELADYNOS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-re...
General Information
| Serial Number | 99637948 |
| Word Mark | ELADYNOS |
| Filing Date | Friday, February 6, 2026 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, June 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 6, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Radius Health, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02110
US |
Trademark Events
| Event Date | Event Description |
| Friday, February 6, 2026 | NEW APPLICATION ENTERED |
| Friday, February 6, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 6, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 3, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, June 3, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
